IIB ActRIIB

Related by string. * IIBS . IIb : Phase IIb clinical . initiate Phase IIb . glycoprotein GP IIb IIIa . glycoprotein IIb IIIa inhibitors . glycoprotein IIb IIIa inhibitor . glycoprotein IIb IIIa . Phase IIb trial . IIB . Phase IIb clinical trials . GP IIb IIIa inhibitors . Phase IIb . modified REGENESIS Phase IIb . randomized Phase IIb . Phase IIb Clinical Trial / : ActRIIB * *

Related by context. Frequent words. (Click for all words.) 60 FGFR 59 novel orally administered 59 optical biosensors 58 coupled receptor GPCR 58 ErbB3 58 molecular chaperone 58 TLR9 agonist 58 synthetic peptides 58 mediate RNAi 58 proteins peptides 57 intracellular signaling pathways 57 MEK inhibitor 57 Hybridon 57 autoimmune inflammatory 57 Archemix Corp. 57 Hsp# inhibitors 57 small molecule 57 anticancer compounds 57 prodrugs 57 Regulus Therapeutics 57 humanized monoclonal antibody 57 epothilone 57 therapeutic monoclonal antibodies 56 SGLT2 56 short interfering RNA 56 antisense drugs 56 prostones 56 biocatalysis 56 Idera Pharmaceuticals 56 Neurogen Corporation 56 nicotinic alpha 7 56 Antisense 56 Wnt signaling pathway 56 selectively inhibits 56 biotherapeutic 56 oncolytic 56 selectively inhibit 56 fusion proteins 56 Nautilus Biotech 56 antibody therapeutics 56 Genaera Corporation 56 Monoclonal Antibody 55 biotherapeutics 55 proteasome inhibitor 55 sphingosine 1 55 novel anticancer 55 CD# expressing 55 plasma proteins 55 OSI Prosidion 55 Vascular Endothelial Growth 55 peroxisome proliferator activated 55 Factor VIIa 55 chemokine 55 Cellzome 55 AVEO Pharmaceuticals Inc. 55 antisense drug 55 Survivin 55 Chemokine 55 E2F 55 phosphoinositide 3 55 preclinical compounds 55 JAK3 55 EnVivo Pharmaceuticals 55 induces apoptosis 55 orally bioavailable 54 nitric oxide donating 54 PEGylation 54 VEGF receptors 54 bio therapeutics 54 peptide therapeutics 54 ATL# [001] 54 Gemin X 54 Inc. Nasdaq IMGN 54 partial agonist 54 dimerization 54 small molecule inhibitors 54 potently silencing specific 54 Panzem R 54 oligonucleotide 54 cancer therapeutics 54 ImmuneRegen BioSciences Inc. 54 synthetic peptide 54 microRNA therapeutics 54 liposomal formulation 54 immuno inflammatory diseases 54 theranostics 54 humanized antibody 54 drug conjugate 54 Epizyme 54 allosteric 54 Ambrx 54 Small Molecule 53 amino acid peptide 53 porphyrin 53 Mersana 53 tyrosine kinase 53 inflammation autoimmune diseases 53 coupled receptors GPCRs 53 Stemgent 53 commercializing therapeutic 53 therapeutics

Back to home page